This will automatically translate the page you were just on to the selected language. (Translation is done by computer and not by our team. To see the Chinese site which was translated by our team, click here.) We are not responsible for failure of the translation engine or inaccuracies from the automatic translation.

'); document.write('

'); } function MM_preloadImages() { //v3.0 var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array(); var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i0&&parent.frames.length) { d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);} if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i 2) { if ((img = MM_findObj(args[2])) != null && !img.MM_init) { img.MM_init = true; img.MM_up = args[3]; img.MM_dn = img.src; if ((nbArr = document[grpName]) == null) nbArr = document[grpName] = new Array(); nbArr[nbArr.length] = img; for (i=4; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) { if (!img.MM_up) img.MM_up = img.src; img.src = img.MM_dn = args[i+1]; nbArr[nbArr.length] = img; } } } else if (event == "over") { document.MM_nbOver = nbArr = new Array(); for (i=1; i < args.length-1; i+=3) if ((img = MM_findObj(args[i])) != null) { if (!img.MM_up) img.MM_up = img.src; img.src = (img.MM_dn && args[i+2]) ? args[i+2] : ((args[i+1])? args[i+1] : img.MM_up); nbArr[nbArr.length] = img; } } else if (event == "out" ) { for (i=0; i < document.MM_nbOver.length; i++) { img = document.MM_nbOver[i]; img.src = (img.MM_dn) ? img.MM_dn : img.MM_up; } } else if (event == "down") { nbArr = document[grpName]; if (nbArr) for (i=0; i < nbArr.length; i++) { img=nbArr[i]; img.src = img.MM_up; img.MM_dn = 0; } document[grpName] = nbArr = new Array(); for (i=2; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) { if (!img.MM_up) img.MM_up = img.src; img.src = img.MM_dn = (args[i+1])? args[i+1] : img.MM_up; nbArr[nbArr.length] = img; } } } //-->

Industry

Previous:
Next:

In 2002, there were 1,466 biotechnology companies in the United States. This number is sure to rise. In the past ten years, the revenues of these companies has more than tripled, growing from $8 billion to $28.6 billion. There were 36 new drug and vaccine approvals in 2002 compared to two in 1992. Also, in 2002 alone, there were 7,763 patents given to assorted genetically engineered products. Biotechnology is going through the phase manufacturing went through during the Industrial Revolution. Growth in this business is booming. This page provides an in-depth view of the products and services bioengineering provides for us today.

Genetic engineering thrives in a realm other than in agriculture and medicine. For example, in the diary industry, rennin is an enzyme used to make cheese. This is the enzyme that separates milk into curd and whey. Traditionally, rennin was taken out of dead calves, but this process sparked much controversy and protest because of morality. Now, rennin can be made in labs because the gene used to make rennin was put into microbes, which produce the rennin. Also, many biological weapons were products of genetic engineering. By using genetic engineering, huge fermentation tanks to grow the organisms were not needed anymore. Biotechnology eliminated all of this.

These only scratch the surface of the usefulness of genetic engineering. These products range from microbe which assist in cleaning oil spills and organisms which can actually eat garbage!

Sources

  • Anderson, Kerby. “Genetic Engineering.” Probe Ministries. 18 Aug. 2004. <http://www.probe.org/docs/gen‑engr.html>.
  • “Biotechnology Industry Facts.” Biotechnology Industry Organization. 18 Aug. 2004. <http://www.bio.org/speeches/pubs/er/statistics.asp>.
  • “Bioterror.” Nova. PBS. 2 Sept. 2003.
  • Henkel, John. “Genetic Engineering.” U.S Food and Drug Administration. 18 Aug. 2004. <http://www.fda.gov//bbs/topics/consumer/geneng.html>.
  • Jefferis, David. BioTech. N.p.: Crabtree Publishing Company, 2002.
  • Jeter, Alexis. “Second Sight.” Reader’s Digest Dec. 2002: 157‑160.
  • Mothers for Natural Law. 18 Aug. 2004 <http://safe‑food.org>.
  • Oleksy, Walter. Miracles of Genetics. Chicago: Children’s Press, 1986.
  • Rantala, M.L., and Arthur J. Milgram, Ph. D. Cloning: For and Against. N.p.: Carus Publishing Company, 1999.
  • Reiss, Michael J, and Roger Straughan. Improving Nature? N.p.: Cambridge University Press, 1996.
  • “Safety and Efficacy Study of rhuFAb V2 (Ranibizumab) to Treat Age‑Related Macular Degeneration.” ClinicalTrials.gov. 18 Aug. 2004. <http://www.clinicaltrials.gov/ct/gui/show/NCT00061594?order=7>.